Skip to main content
RecallRadar
FDAClass III

Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Onl… Recalled: Failed Stability Specifications: Out of specification stability result for the protein co…

Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6… was recalled on August 19, 2026 in cooperation with the U.S. Food and Drug Administration because failed Stability Specifications: Out of specification stability result for the protein concentration profile..

Is my unit affected?

Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01

Model, lot & date codes to check

Lot#: 1221973, Exp 3/24/2027

Units affected: 3,002 vials

Where it was sold: MO, TN

Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.

What's the hazard?

Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

Class III means the product is unlikely to cause a health problem, but it violates FDA labeling or manufacturing rules.

Your remedy & how to claim it

Stop using the product. Return it to the place of purchase for a refund, or dispose of it. Contact the recalling firm with questions.

Contact: Recalling firm: Chiesi USA, Inc.

Not sure what you're entitled to? Read our guide: what to do if your product is recalled.

Official recall notice

Always confirm details on the official notice from the U.S. Food and Drug Administration before acting.

View official notice →

Get recall alerts

Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.

Double opt-in: we only email you after you confirm. No spam, ever.